查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
胰岛素帮浦市场：按类型、产品、配件、疾病、年龄层、最终用户、通路、地区、机会、预测，2017-2031
市场调查报告书
商品编码
1422072

胰岛素帮浦市场：按类型、产品、配件、疾病、年龄层、最终用户、通路、地区、机会、预测，2017-2031

Insulin Pumps Market Assessment, By Type, By Product, By Accessories, By Disease Indication, By Age Group, By End-user, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

全球胰岛素帮浦市场规模预计将从2023年的67.8亿美元成长到2031年的171.2亿美元，预测期内复合年增长率为12.28%。

推动市场成长的关键因素包括糖尿病盛行率迅速上升、对方便易用的胰岛素输送设备的需求不断增长、技术进步、政府举措以及老年人口的增加等等。

糖尿病盛行率上升

过去 30 年来，全球糖尿病患者数量显着增加，从 1.08 亿跃升至 4.2 亿。其中，美洲有6200万糖尿病患者，对全球胰岛素帮浦市场影响重大。值得注意的是，自 1980 年以来，该地区的数字增加了两倍多，因此实际数字可能要高得多。与糖尿病相关的健康问题的负担是巨大的并且不断增加。过去20年来，全球与糖尿病相关的死亡率增加了70%。

自动胰岛素剂量演算法的需求不断增加

自动胰岛素给药演算法的需求不断增长，代表着糖尿病照护的重要转变。这些技术先进的演算法提供精确和自适应的胰岛素控制。随着全球糖尿病盛行率的增加，对简化和改善胰岛素管理的创新解决方案的需求很大。

政府的努力

政府措施对于塑造胰岛素帮浦市场的特征、影响先进技术的可及性、定价和采用至关重要。政府的这些努力对于解决困扰全球大量人口的糖尿病问题至关重要。政府越支持病患自我管理，就越能降低长期医疗成本。

本报告调查了全球胰岛素帮浦市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构、影响市场成长的因素分析、案例研究、竞争格局、主要简介公司等

目录

第一章研究方法论

第二章 专案范围与定义

第三章 COVID-19对全球胰岛素帮浦市场的影响

第 4 章执行摘要

第五章 全球胰岛素帮浦市场展望

  • 市场规模/预测
  • 按类型
    • 独立胰岛素帮浦
    • 带有集成传感器的胰岛素泵
  • 按产品
    • 泵
    • 消耗品
  • 按配件分类
    • 胰岛素储液器或药筒
    • 胰岛素套件插入装置
    • 电池
  • 按疾病分类
    • 1型糖尿病
    • 2型糖尿病
  • 按年龄段
    • 成人
    • 孩子
    • 两个都
  • 按最终用户
    • 医院
    • 诊所
    • 家用
    • 实验室
  • 按分销渠道
    • 零售店
    • 医院药房
    • 电子商务
  • 按地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 按公司划分的市场份额

第六章全球胰岛素帮浦市场展望：按地区

  • 北美
  • 欧洲
  • 南美洲
  • 亚太地区
  • 中东/非洲

第七章 市场测绘

  • 按类型
  • 按产品
  • 按配件分类
  • 按疾病分类
  • 按年龄段
  • 按最终用户
  • 按分销渠道
  • 按地区

第八章 宏观环境与产业结构

  • 供需分析
  • 进出口分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第八章市场动态

  • 成长动力
  • 生长抑制因素（问题/障碍）

第 9 章 监理架构/创新

  • 临床试验
  • 专利态势
  • 监管审批
  • 创新/最新技术

第十章 主要公司情况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名市场领导者的市场收入分析
  • 併购/合资（如适用）
  • SWOT分析（5家参与企业）
  • 专利分析（如果适用）

第11章价格分析

第十二章案例研究

第十四章 主要公司展望

  • Medtronic plc.
  • Abbott Laboratories
  • Ypsomed AG
  • CamDiab Ltd.
  • Phillips-Medisize Corporation
  • Modular Medical, Inc.
  • Tandem Diabetes Care, Inc.
  • Roche Diabetes Care, Inc.
  • Beta Bionics
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • WUXI APEX Medical Corporation
  • SOOIL Developments Co., Ltd.

第十五章战略建议

第十六章关于我们公司/免责声明

Product Code: MX10937

Global insulin pumps market size was valued at USD 6.78 billion in 2023, which is expected to reach USD 17.12 billion in 2031, with a CAGR of 12.28% for the forecast period between 2024 and 2031F. The key factors propelling the global insulin pumps market include a surge in the prevalence of diabetes, a growing need for insulin delivery devices that offer convenience and user-friendliness, advancements in technology, governmental efforts, and an increasing elderly population.

The global insulin pumps market is expected to gain a substantial transformation and expansion, driven by a convergence of factors that are reshaping the realm of diabetes management. One of the principal catalysts propelling the market's growth is the escalating prevalence of diabetes. The alarming surge in diabetes cases, encompassing both type 1 and type 2, has generated an urgent requirement for dependable and convenient means of administering insulin. As patients and healthcare practitioners seek more efficacious methods for regulating blood glucose levels, insulin pumps have emerged as the favored choice due to their capacity to deliver precise doses with minimal exertion.

Moreover, the global insulin pumps market is capitalizing on technological advancements. The incorporation of continuous glucose monitoring (CGM), the emergence of intelligent insulin pumps, and improvements in user interfaces have transformed these devices into more user-friendly and efficient tools. Patients are increasingly in search of devices that provide precise insulin delivery and seamlessly integrate with smartphones and other digital platforms, enabling real-time data monitoring and management.

Additionally, governmental efforts aimed at alleviating the diabetes burden and associated healthcare costs are fostering the global insulin pumps market's growth. Public health initiatives and policies designed to encourage the adoption of advanced diabetes management technologies have contributed to heightened accessibility and affordability of insulin pumps.

Rising Diabetes Prevalence

Globally, the population of individuals living with diabetes (PLWD) has witnessed a substantial surge over the past three decades, soaring from 108 million to 420 million. Among these, 62 million individuals with diabetes reside in the Americas, largely impacting the global insulin pumps market. Notably, the number has ballooned by more than threefold in the region since 1980, with the actual figure being potentially higher, as 40% of PLWD remain unaware of their condition, going undiagnosed. The burden posed by diabetes-related health issues is both significant and escalating. Within two decades, diabetes-related mortality has escalated by a staggering 70% worldwide.

In the Americas, it stands as the sixth leading cause of death and the seventh leading contributor to years of life lost prematurely. In the region, diabetes, inclusive of diabetes-related kidney disease, accounts for the premature loss of more than eight million years of life annually. Astonishingly, almost half of premature deaths in the Americas are attributed to diabetes. Furthermore, over a span of just 20 years, the number of disability-adjusted life years (DALYs) attributable to diabetes has surged by 88%, reaching a remarkable 97% increase among men. Presently, diabetes ranks as the second leading cause of DALYs globally, trailing behind ischemic heart disease.

Rising Demand for Algorithms for Automated Insulin Delivery

The increasing desire for algorithms in automated insulin delivery signifies a significant shift in diabetes care. These algorithms, powered by advanced technologies, offer precise and adaptable insulin control. With the global diabetes prevalence on the rise, there's a pronounced demand for inventive solutions to simplify and improve insulin management. The growing demand for insulin delivery algorithms is opening doors for companies specializing in these technologies. Firms capable of creating precise, dependable, and user-friendly algorithms are poised to thrive in the expanding global insulin pumps market. As an example, in May 2023, Beta Bionics obtained approval from the US Food and Drug Administration (FDA) for its iLet ACE Pump and iLet Dosing Decision Software, designed for individuals aged six years and older with type 1 diabetes. These components, when used in conjunction with a compatible integrated continuous glucose monitor (iCGM), constitute the iLet Bionic Pancreas system. The innovative system employs an algorithm to assess and regulate insulin delivery.

Government Initiatives

Government actions are central in molding the global insulin pumps market's characteristics, impacting its accessibility, affordability, and the uptake of advanced technologies for managing diabetes. These governmental endeavors are vital in confronting the escalating issue of diabetes, a persistent metabolic ailment marked by elevated blood glucose levels that afflict a vast global population. The greater the extent to which governments can assist patients in acquiring the skills for self-management, the lower the long-term healthcare costs it will incur due to improved health outcomes and reduced costs for the entire population.

For instance, in March 2023, the government of New Brunswick unveiled its plan to alleviate the financial burden associated with diabetes. Minister of Finance Ernie Steeves announced a budget allocation of USD 2.1 million to improve diabetes management. In New Brunswick, annual expenses directly borne by individuals can surpass USD 18,000 for those with Type 1 diabetes and USD 10,000 for those with Type 2 diabetes, as reported by Diabetes Canada. The province's announcement is expected to target and alleviate a significant portion of the high costs linked with diabetes.

Growing Demand for Insulin Patch

The increasing desire for insulin patches marks a noteworthy transformation in the global insulin pump market. Insulin patches present a non-intrusive and unobtrusive means of administering insulin, potentially enhancing the well-being of individuals living with diabetes. The surging appeal of these patches can be traced to their convenience, precision, and ability to address certain obstacles linked to conventional insulin delivery approaches.

As an illustration, in May 2023, Medtronic plc, a prominent player in healthcare technology, disclosed its intent to finalize a series of agreements aimed at acquiring EOFlow Co. Ltd., the creator of the EOPatch device, an insulin delivery device that is both tubeless and disposable, designed to be worn on the body. The incorporation of EOFlow into Medtronic's portfolio, in conjunction with the company's Meal Detection Technology algorithm and state-of-the-art continuous glucose monitor (CGM), is poised to enhance Medtronic's capacity to cater to the diverse requirements of individuals with diabetes, regardless of their stage in the treatment process or their preferences for insulin delivery methods. Such convenience-based products are the leading cause for drastic growth in global insulin pump market.

Increasing Demand for Type 1 Diabetes Solutions

The intricate challenges of mealtimes in type 1 diabetes management drive the demand for solutions and stimulate growth in the global insulin pumps market. Balancing insulin dosages with carbohydrate intake, managing blood sugar spikes post-meal, and predicting meal content can be formidable tasks. The challenge lies in maintaining glycemic control and preventing hypoglycemia or hyperglycemia during and after meals. CGM, advanced insulin delivery systems, and mealtime planning have become essential strategies to address these challenges and enhance diabetes management. As an example, in April 2023, Medtronic plc, a leading global medical technology company, revealed that the U.S. Food and Drug Administration (FDA) had approved its MiniMed 780G system, featuring the Guardian 4 sensor, which eliminates the need for fingerstick tests when using SmartGuard technology. This achievement signifies the approval of the sole system incorporating meal detection technology, enabling automatic adjustments and corrections to sugar levels every 5 minutes, proving highly advantageous for individuals with type 1 diabetes.

Impact of COVID-19

Patients with T1DM using insulin pumps experienced a milder impact from COVID-19 lockdown measures on their glycemic control than those using insulin pens. The adoption of telemedicine and online consultations yielded substantial benefits, optimizing time allocation per patient, and improving physician-patient communication. Physicians could remotely monitor disease progression, resulting in significant improvements. Notably, insulin pump users exhibited superior glycemic stability and better resilience to pandemic-related stress and anxiety compared to pen users. The advantage may be attributed to the continuous glycemic monitoring system, which is likely contributed to fewer hyperglycemic episodes in the group. However, the pandemic had some adverse effects on the global insulin pumps market, as several insulin pump manufacturers deferred or put on hold the introduction of new products or enhancements because of the uncertainties stemming from the pandemic.

Key Players Landscape and Outlook

Collaborative efforts in the global insulin pumps market are witnessing a surge as companies aim to pioneer novel and inventive technologies for the betterment of individuals with diabetes. Recent instances of such collaborations include Medtronic teaming up with Bigfoot Biomedical to co-create a hybrid closed-loop insulin delivery system, and Tandem Diabetes Care partnering with Dexcom to seamlessly integrating their insulin pumps with Dexcom's continuous glucose monitoring (CGM) system. These partnerships are pivotal in expediting the development of next-generation insulin pumps characterized by enhanced accuracy, convenience, and user-friendliness.

For example, in August 2023, Modular Medical, Inc. joined forces with Phillips-Medisize to broaden the array of insulin delivery options. Leveraging its extensive and diverse supplier network, as well as its profound expertise in medical devices and diabetes management, Phillips-Medisize took charge of designing and developing the manufacturing and assembly processes for the MODD1 Insulin Delivery System. The collaboration has expedited the development journey for Modular Medical and has paved the way for substantial scalability and a state of readiness for market launch.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of Covid-19 on Global Insulin Pumps Market

4. Executive Summary

5. Global Insulin Pumps Market Outlook, 2017-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Standalone Insulin Pumps
    • 5.2.2. Sensor Integrated Insulin Pumps
  • 5.3. By Product
    • 5.3.1. Pumps
      • 5.3.1.1. Tethered Pumps
      • 5.3.1.2. Patch Pumps
      • 5.3.1.3. Others
    • 5.3.2. Consumables
  • 5.4. By Accessories
    • 5.4.1. Insulin Reservoir or Cartridges
    • 5.4.2. Insulin Set Insertion Devices
    • 5.4.3. Battery
  • 5.5. By Disease Indication
    • 5.5.1. Type 1 Diabetes
    • 5.5.2. Type 2 Diabetes
  • 5.6. By Age Group
    • 5.6.1 Adult
    • 5.6.2. Paediatrics
    • 5.6.3. Both
  • 5.7. By End-user
    • 5.7.1. Hospitals
    • 5.7.2. Clinics
    • 5.7.3. Homeware
    • 5.7.4. Laboratories
  • 5.8. By Distribution Channel
    • 5.6.1 Retail Stores
    • 5.6.2 Hospital Pharmacy
    • 5.6.3 E-commerce
  • 5.9. By Region
    • 5.9.1. North America
    • 5.9.2. South America
    • 5.9.3. Europe
    • 5.9.4. Asia-Pacific
    • 5.9.5. Middle East and Africa
  • 5.10. By Company Market Share (%), 2023

6. Global Insulin Pumps Market Outlook, By Region, 2017-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. Standalone Insulin Pumps
      • 6.1.2.2. Sensor Integrated Insulin Pumps
    • 6.1.3. Product
      • 6.1.3.1. Pumps
      • 6.1.3.1.1. Tethered Pumps
      • 6.1.3.1.2. Patch Pumps
      • 6.1.3.1.3. Others
      • 6.1.3.2. Consumables
    • 6.1.4. By Accessories
      • 6.1.4.1. Insulin Reservoir or Cartridges
      • 6.1.4.2. Insulin Set Insertion Devices
      • 6.1.4.3. Battery
    • 6.1.5. By Disease Indication
      • 6.1.5.1. Type 1 Diabetes
      • 6.1.5.2. Type 2 Diabetes
    • 6.1.6. By Age Group
      • 6.1.6.1. Adult
      • 6.1.6.2. Pediatric
      • 6.1.6.3. Both
    • 6.1.7. By End-user
      • 6.1.7.1. Hospitals
      • 6.1.7.2. Clinics
      • 6.1.7.3. Homeware
      • 6.1.7.4. Laboratories
    • 6.1.8. By Distribution Channel
      • 6.1.8.1. Retail Stores
      • 6.1.8.2. Hospital Pharmacy
      • 6.1.8.3. E-commerce
    • 6.1.9. United States*
      • 6.1.9.1. Market Size & Forecast
      • 6.1.9.1.1. Value
      • 6.1.9.1.2. Volume
      • 6.1.9.2. By Type
      • 6.1.9.2.1. Standalone Insulin Pumps
      • 6.1.9.2.2. Sensor Integrated Insulin Pumps
      • 6.1.9.3. By Product
      • 6.1.9.3.1. Pumps
      • 6.1.9.3.1.1. Tethered Pumps
      • 6.1.9.3.1.2. Patch Pumps
      • 6.1.9.3.1.3. Others
      • 6.1.9.3.2. Consumables
      • 6.1.9.4. By Accessories
      • 6.1.9.4.1. Insulin Reservoir or Cartridges
      • 6.1.9.4.2. Insulin Set Insertion Devices
      • 6.1.9.4.3. Battery
      • 6.1.9.5. By Disease Indication
      • 6.1.9.5.1. Type 1 Diabetes
      • 6.1.9.5.2. Type 2 Diabetes
      • 6.1.9.6. By Age Group
      • 6.1.9.6.1. Adult
      • 6.1.9.6.2. Pediatric
      • 6.1.9.6.3. Both
      • 6.1.9.7. By End-user
      • 6.1.9.7.1. Hospitals
      • 6.1.9.7.2. Clinics
      • 6.1.9.7.3. Homeware
      • 6.1.9.7.4. Laboratories
      • 6.1.9.8. By Distribution Channel
      • 6.1.9.8.1. Retail Stores
      • 6.1.9.8.2. Hospital Pharmacy
      • 6.1.9.8.3. E-commerce
    • 6.1.10. Canada
    • 6.1.11. Mexico

All segments will be provided for all regions and countries covered:

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Product
  • 7.3. By Accessories
  • 7.4. By Disease Indication
  • 7.5. By Age Group
  • 7.6. By End-user
  • 7.7. By Distribution Channel
  • 7.8. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Medtronic plc.
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Abbott Laboratories
  • 14.3. Ypsomed AG
  • 14.4. CamDiab Ltd.
  • 14.5. Phillips-Medisize Corporation
  • 14.6. Modular Medical, Inc.
  • 14.7. Tandem Diabetes Care, Inc.
  • 14.8. Roche Diabetes Care, Inc.
  • 14.9. Beta Bionics
  • 14.10. Insulet Corporation
  • 14.11. Jiangsu Delfu Medical Device Co., Ltd.
  • 14.12. WUXI APEX Medical Corporation
  • 14.13. SOOIL Developments Co., Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 5. Global Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 6. Global Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 7. Global Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 8. Global Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 10. Global Insulin Pumps Market Share (%), By Region, 2017-2031F
  • Figure 11. North America Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. North America Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 13. North America Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 14. North America Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 15. North America Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 16. North America Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 17. North America Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 18. North America Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 19. North America Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 20. North America Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 21. United States Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. United States Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 23. United States Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 24. United States Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 25. United States Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 26. United States Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 27. United States Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 28. United States Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 29. United States Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 30. Canada Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 31. Canada Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 32. Canada Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 33. Canada Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 34. Canada Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 35. Canada Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 36. Canada Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 37. Canada Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 38. Canada Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 39. Mexico Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. Mexico Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 41. Mexico Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 42. Mexico Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 43. Mexico Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 44. Mexico Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 45. Mexico Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 46. Mexico Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 47. Mexico Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 48. Europe Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Europe Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 50. Europe Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 51. Europe Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 52. Europe Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 53. Europe Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 54. Europe Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 55. Europe Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 56. Europe Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 57. Europe Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 58. Germany Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. Germany Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 60. Germany Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 61. Germany Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 62. Germany Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 63. Germany Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 64. Germany Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 65. Germany Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 66. Germany Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 67. France Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. France Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 69. France Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 70. France Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 71. France Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 72. France Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 73. France Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 74. France Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 75. France Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 76. Italy Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Italy Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 78. Italy Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 79. Italy Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 80. Italy Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 81. Italy Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 82. Italy Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 83. Italy Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 84. Italy Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 85. United Kingdom Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. United Kingdom Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 87. United Kingdom Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 88. United Kingdom Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 89. United Kingdom Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 90. United Kingdom Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 91. United Kingdom Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 92. United Kingdom Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 93. United Kingdom Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. Russia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Russia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 96. Russia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 97. Russia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 98. Russia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 99. Russia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 100. Russia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 101. Russia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 102. Russia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 103. Netherlands Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 104. Netherlands Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 105. Netherlands Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 106. Netherlands Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 107. Netherlands Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 108. Netherlands Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 109. Netherlands Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 110. Netherlands Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 111. Netherlands Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 112. Spain Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 113. Spain Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 114. Spain Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 115. Spain Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 116. Spain Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 117. Spain Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 118. Spain Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 119. Spain Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 120. Spain Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 121. Turkey Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Turkey Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 123. Turkey Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 124. Turkey Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 125. Turkey Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 126. Turkey Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 127. Turkey Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 128. Turkey Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 129. Turkey Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 130. Poland Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 131. Poland Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 132. Poland Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 133. Poland Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 134. Poland Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 135. Poland Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 136. Poland Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 137. Poland Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 138. Poland Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 139. South America Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. South America Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 141. South America Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 142. South America Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 143. South America Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 144. South America Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 145. South America Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 146. South America Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 147. South America Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 148. South America Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 149. Brazil Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 150. Brazil Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 151. Brazil Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 152. Brazil Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 153. Brazil Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 154. Brazil Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 155. Brazil Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 156. Brazil Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 157. Brazil Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 158. Argentina Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 159. Argentina Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 160. Argentina Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 161. Argentina Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 162. Argentina Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 163. Argentina Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 164. Argentina Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 165. Argentina Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 166. Argentina Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 167. Asia-Pacific Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Asia-Pacific Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 169. Asia-Pacific Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 170. Asia-Pacific Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 171. Asia-Pacific Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 172. Asia-Pacific Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 173. Asia-Pacific Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 174. Asia-Pacific Insulin Pumps Market Share (%), By End-user, In USD Billion, 2016-2030
  • Figure 175. Asia-Pacific Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 176. Asia-Pacific Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 177. India Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 178. India Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 179. India Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 180. India Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 181. India Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 182. India Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 183. India Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 184. India Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 185. India Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 186. China Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 187. China Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 188. China Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 189. China Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 190. China Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 191. China Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 192. China Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 193. China Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 194. China Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Japan Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Japan Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 197. Japan Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 198. Japan Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 199. Japan Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 200. Japan Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 201. Japan Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 202. Japan Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 203. Japan Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 204. Australia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 205. Australia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 206. Australia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 207. Australia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 208. Australia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 209. Australia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 210. Australia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 211. Australia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 212. Australia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 213. Vietnam Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 214. Vietnam Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 215. Vietnam Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 216. Vietnam Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 217. Vietnam Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 218. Vietnam Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 219. Vietnam Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 220. Vietnam Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 221. Vietnam Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 222. South Korea Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 223. South Korea Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 224. South Korea Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 225. South Korea Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 226. South Korea Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 227. South Korea Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 228. South Korea Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 229. South Korea Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 230. South Korea Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 231. Indonesia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 232. Indonesia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 233. Indonesia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 234. Indonesia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 235. Indonesia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 236. Indonesia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 237. Indonesia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 238. Indonesia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 239. Indonesia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 240. Philippines Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 241. Philippines Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 242. Philippines Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 243. Philippines Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 244. Philippines Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 245. Philippines Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 246. Philippines Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 247. Philippines Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 248. Philippines Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 249. Middle East & Africa Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 250. Middle East & Africa Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 251. Middle East & Africa Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 252. Middle East & Africa Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 253. Middle East & Africa Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 254. Middle East & Africa Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 255. Middle East & Africa Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 256. Middle East & Africa Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 257. Middle East & Africa Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 258. Middle East & Africa Insulin Pumps Market Share (%), By Country, 2017-2031F
  • Figure 259. Saudi Arabia Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 260. Saudi Arabia Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 261. Saudi Arabia Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 262. Saudi Arabia Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 263. Saudi Arabia Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 264. Saudi Arabia Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 265. Saudi Arabia Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 266. Saudi Arabia Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 267. Saudi Arabia Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 268. UAE Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 269. UAE Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 270. UAE Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 271. UAE Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 272. UAE Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 273. UAE Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 274. UAE Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 275. UAE Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 276. UAE Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 277. South Africa Insulin Pumps Market, By Value, In USD Billion, 2017-2031F
  • Figure 278. South Africa Insulin Pumps Market, By Volume, In Millions, 2017-2031F
  • Figure 279. South Africa Insulin Pumps Market Share (%), By Type, 2017-2031F
  • Figure 280. South Africa Insulin Pumps Market Share (%), By Product, 2017-2031F
  • Figure 281. South Africa Insulin Pumps Market Share (%), By Accessories, 2017-2031F
  • Figure 282. South Africa Insulin Pumps Market Share (%), By Disease Indication, 2017-2031F
  • Figure 283. South Africa Insulin Pumps Market Share (%), By Age Group, 2017-2031F
  • Figure 284. South Africa Insulin Pumps Market Share (%), By End-user, 2017-2031F
  • Figure 285. South Africa Insulin Pumps Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 287. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 288. By Accessories Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 289. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 290. By Age Group Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 291. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 292. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 293. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023